LATEST ARTICLES

Access & Prescribing (Australia & Global)

Telemedicine Becomes Primary Channel for Global Medical Cannabis Access Amid Regulatory Scrutiny

Steven Gothrinet -
Equities, Investment & Market Trends

Federal Medical Cannabis Reclassification to Schedule III Alters Financial Landscape for US Operators

Steven Gothrinet -
Global Regulatory Updates

Industrial Hemp Market Faces Regulatory Challenges as Stakeholders Seek Clearer Policy Frameworks

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Israel Proposes Significant Overhaul of Medical Cannabis Guidelines, Shifting Responsibility to Health Funds

Gillian Jalimnson -
Equities, Investment & Market Trends

US Industrial Hemp Market Faces Policy Challenges Amidst Regulatory Ambiguity

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Crown Dependencies Urged to Consider Cannabis Policy Pilot Schemes for Data Collection

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Trump Administration Relaxes Federal Medical Cannabis Controls, Offering Significant Tax Relief to Industry

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Maine Issues Advisory After Medical Cannabis Found to Contain Unsafe Levels of Mold and Pesticides

Gillian Jalimnson -
Access & Prescribing (Australia & Global)

West Virginia Supreme Court Examines Medical Cannabis Odor as Probable Cause for Home Searches

Steven Gothrinet -
Access & Prescribing (Australia & Global)

Rescheduling to Schedule III Expected to Drive Medical Cannabis Program Enrollment Growth

Steven Gothrinet -
1234...279Page 3 of 279

MOST POPULAR

Clinical Trials & Medical Research

Health, Wellness And American Cannabis Use

Terry Lassitenaz -
A new survey report indicates the primary reasons Americans are using cannabis in relation to health and wellness.Conducted by The Harris Poll on behalf...
Read more
Clinical Trials & Medical Research

Medical Cannabis, Anxiety And Depression – Study Results

Gillian Jalimnson -
A retrospective study investigating how medical cannabis impacts anxiety and depression outcomes has reported positive results.The study involving 7,362 Canadian patients with an average...
Read more
Access & Prescribing (Australia & Global)

Alabama Patients Face Extended Wait For Medical Cannabis

Steven Gothrinet -
It's looking as though patients in Alabama still have a lengthy wait before they'll be able to get access to medical cannabis in their...
Read more
Access & Prescribing (Australia & Global)

Kentucky Medical Cannabis Advisory Committee Named

Terry Lassitenaz -
Kentucky Governor Andy Beshear is continuing to push ahead on medical cannabis, making good on a couple of important initial steps he committed to.In...
Read more
Load more